Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 21.8% | 21.6% | 20.3% | 10.7% | 16.8% | 20.1% | 18.8% | 13.0% | 15.0% | 21.6% | 14.3% | 16.5% | 14.6% | 16.9% | 15.2% | 16.3% | 23.7% | 30.9% | 16.2% | 14.6% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 9.6%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for Quest Diagnostics Incorporated have been 19.9% over the past three years, and 20.5% over the past five years.
As of today, Quest Diagnostics Incorporated's Return on Equity (ROE) is 9.6%, which is higher than industry median of (16.4%). It indicates that Quest Diagnostics Incorporated's Return on Equity (ROE) is Good.